BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30388719)

  • 1. Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer.
    Tezel C; Dogruyol T; Alpay L; Akyıl M; Evman S; Metin S; Baysungur V; Yalcinkaya I
    Thorac Cardiovasc Surg; 2020 Mar; 68(2):183-189. PubMed ID: 30388719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
    Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where is the boundary between N1 and N2 stations in lung cancer?
    Asamura H; Suzuki K; Kondo H; Tsuchiya R
    Ann Thorac Surg; 2000 Dec; 70(6):1839-45; discussion 1845-6. PubMed ID: 11156081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
    Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
    Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer.
    Yoshida Y; Yotsukura M; Nakagawa K; Watanabe H; Motoi N; Watanabe SI
    Thorac Cardiovasc Surg; 2021 Jun; 69(4):366-372. PubMed ID: 32634835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    Razi SS; Nguyen D; Villamizar N
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.